Previous 10 | Next 10 |
Existing Notes Amended as Part of Plan to Strengthen Balance Sheet and Regain Nasdaq Listing Standards Compliance Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based (Polymerase Chain Reaction) DNA manufac...
Five-year Agreement to supply Applied DNA Unique Marks for use in a range of Montblanc inks for use in writing instruments Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA”, the “Company”), a leader in PCR-based DNA manufacturing for product aut...
Orders Reflect Growing Interest across the Biotech Industry for Bacteria-Free, Plasmid-Free Therapies LineaRx, Inc., a wholly-owned subsidiary of Applied DNA Sciences , Inc. (“Applied DNA or the Company,” NASDAQ:APDN), announced today that it has received multiple purcha...
Interest in large-scale Linear DNA for nucleic acid-based therapies continues to rise LineaRx, Inc. a wholly-owned subsidiary of Applied DNA Sciences , Inc. (NASDAQ: APDN), announced today that it has shipped multiple customized linear DNA amplicons to Evotec SE, a well-known therapeu...
ETCH biotrace to Combine Applied DNA’s DNA tag-based Forensic Traceability and Authenticity with TruTrace's Industry Blockchain Hub to Deliver Unparalleled Tag-Test-Track Capabilities to Global Cannabis and Hemp Industry Applied DNA Sciences , Inc. (“Applied DNA”,...
PLOS ONE Publication Details Proprietary Method to Distinguish Legitimate Pharmaceutical Drugs from Counterfeit Products Including Counterfeit Opioids Applied DNA Sciences , Inc. (NASDAQ: APDN), announced today that its scientific paper entitled, ‘ Rapid authentication of p...
Includes Implementation of TheraCann’s ETCH biotrace™ platform Utilizing Technology from Applied DNA Applied DNA Sciences Inc. (NASDAQ:APDN) (“Applied DNA”), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions,...
CertainT Platform Provides Evidence of Recycled Polyester Filament and Fiber Content Claims in Asia, Americas and EMEA Applied DNA Sciences , Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), provides an update today on its accomplishments toward comme...
Forensic Authentication of Cotton in Fiber, Yarn, Fabric and Finished Goods Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), today announced that it has closed the loop on traceability for Egyptian Pima using DNA-based genotyping a...
LineaRx, a wholly-owned subsidiary of Applied DNA Sciences (NASDAQ: APDN ), is in process of designing new, custom amplicons for an existing customer in the in vitro diagnostics market. More news on: Applied DNA Sciences, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Applied DNA Sciences Inc. Company Name:
APDN Stock Symbol:
NASDAQ Market:
Applied DNA Sciences Inc. Website:
2024-04-25 09:02:03 ET Applied Dna Sciences Inc (APDN) announced stock split at a ratio of 1-for-20 on 2024-04-25 ... Full story available on KlickAnalytics.com
STONY BROOK, NY / ACCESSWIRE / April 22, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-20 stock split of its common stock, to be effective as of 12:01 a.m. Eastern Time on Thursd...
- Project To Increase RNAP Manufacturing Capacity and Reduce Unit Costs of Goods - - Project Slated for Completion Coincident with Company's Planned Initiation of GMP Manufacturing for Linea ™ DNA IVT Templates - STONY BROOK, NY and JUPITER, FL / ACCESSWIRE / March 18, 2024 /...